Gene · 10313
Papers1,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,763
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synthesis of nano-hydroxyapatite using emulsion, pyrolysis, combustion, and sonochemical methods and biogenic sources: a review. | RSC Adv | 2024 | 38259993 | PubTator, text mining | PubMed |
| Synthesis of Tubular Hydroxyapatite and Its Application in Polycaprolactone Scaffold Materials. | J Funct Biomater | 2024 | 38248689 | PubTator, text mining | PubMed |
| The integration of multidisciplinary approaches revealed PTGES3 as a novel drug target for breast cancer treatment. | J Transl Med | 2024 | 38245717 | PubTator, text mining | PubMed |
| Effects of mechanical properties of carbon-based nanocomposites on scaffolds for tissue engineering applications: a comprehensive review. | Nanoscale Adv | 2024 | 38235087 | PubTator, text mining | PubMed |
| Enhancement of antimicrobial properties by metals doping in nano-crystalline hydroxyapatite for efficient biomedical applications. | Heliyon | 2024 | 38192860 | PubTator, text mining | PubMed |
| Molecular Modulators and Receptors of Selective Autophagy: Disease Implication and Identification Strategies. | Int J Biol Sci | 2024 | 38169614 | PubTator, text mining | PubMed |
| Lipid overload-induced RTN3 activation leads to cardiac dysfunction by promoting lipid droplet biogenesis. | Cell Death Differ | 2024 | 38017147 | PubTator, text mining | PubMed |
| A novel porous lignocellulosic standing hierarchical hydroxyapatite for enhanced aqueous copper(II) removal. | Sci Total Environ | 2024 | 38016558 | PubTator, text mining | PubMed |
| Integration of single-cell and bulk RNA-sequencing to analyze the heterogeneity of hepatocellular carcinoma and establish a prognostic model. | Cancer Rep (Hoboken) | 2024 | 37994394 | PubTator, text mining | PubMed |
Comparative evaluation of the effect of 37% orthophosphoric acid pre-etching on the microtensile enamel bond strength using universal adhesive and two-step self-etch adhesive systems - An in vitro study. | J Conserv Dent Endod | 2023 | 38292748 | PubTator, text mining | PubMed |
| Hydroxyapatite-Based Coatings on Silicon Wafers and Printed Zirconia. | J Funct Biomater | 2023 | 38248678 | PubTator, text mining | PubMed |
| Salvia officinalis-Hydroxyapatite Nanocomposites with Antibacterial Properties. | Polymers (Basel) | 2023 | 38231963 | PubTator, text mining | PubMed |
| CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections. | Int J Mol Sci | 2023 | 38203503 | PubTator, text mining | PubMed |
| Cheminformatics-Based Design and Synthesis of Hydroxyapatite/Collagen Nanocomposites for Biomedical Applications. | Polymers (Basel) | 2023 | 38201750 | PubTator, text mining | PubMed |
| Cell-type specific role of autophagy in the liver and its implications in non-alcoholic fatty liver disease. | World J Hepatol | 2023 | 38192406 | PubTator, text mining | PubMed |
| Size-Dependent Cytotoxicity, Adhesion, and Endocytosis of Micro-/Nano-hydroxyapatite Crystals in HK-2 Cells. | ACS Omega | 2023 | 38144057 | PubTator, text mining | PubMed |
| Quantitative Detection Technology for Geometric Deformation of Pipelines Based on LiDAR. | Sensors (Basel) | 2023 | 38139607 | PubTator, text mining | PubMed |
| Model-Based Design to Enhance Neotissue Formation in Additively Manufactured Calcium-Phosphate-Based Scaffolds. | J Funct Biomater | 2023 | 38132817 | PubTator, text mining | PubMed |
| 3D printed zirconia used as dental materials: a critical review. | J Biol Eng | 2023 | 38129905 | PubTator, text mining | PubMed |
| p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells. | Cell Death Dis | 2023 | 38123597 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10313/papers?page=6